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Case Report
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Abstract
Cystic trophoblastic tumor (CTT) is an uncommon trophoblastic proliferation of germ cell tumor origin, mostly reported
in post-chemotherapy metastases of testicular germ cell tumors and rarely primary untreated testicular tumors. To date,
we are not aware of occurrence in a non-testicular tumor. A 12-year-old boy presented with limb swelling, increased
appetite, weight gain, and precocious puberty. Evaluation revealed right frontal lobe mass and elevated a-fetoprotein and
b-human chorionic gonadotrophin. After response to neoadjuvant chemotherapy, the tumor was resected. Microscopically, the resection contained predominantly smooth muscle tissue with scattered small foci of glandular teratoma
and CTT. Immunohistochemistry (SALL4, glypican 3) revealed no residual yolk sac tumor. Fluorescence in situ hybridization revealed gain of chromosome 12p. The patient has been disease-free for 13 years. This report expands the
spectrum of primary central nervous system germ cell tumors with the occurrence of CTT in this site.
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Introduction
Cystic trophoblastic tumor (CTT) was first described by
Ulbright et al in post-chemotherapy retroperitoneal lymph
node dissection specimens from patients with metastatic
nonseminomatous germ cell tumors.1 Subsequently, less
than a hundred such cases have been described in the literature, mostly in post-chemotherapy specimens, and rarely in
primary untreated testicular tumors.2 One of the proposed
hypotheses for the pathogenesis of this lesion is that it represents regression of choriocarcinoma. To our knowledge,
CTT has not been described in an extragonadal germ cell
tumor. A minority occur in primary chemotherapy-naı̈ve
testicular tumors.1,3 Despite being a trophoblastic neoplasm
that often is found in post-chemotherapy metastases, the
behavior of these metastatic lesions has been associated with
good prognosis, approximating that of teratoma.3 We report
the development of CTT in a primary central nervous system
germ cell tumor, which has not been previously described.

Materials and Methods
Four-micrometer-thick sections were prepared from the
specimen for hematoxylin and eosin staining and

immunohistochemistry. Immunohistochemical staining
was performed in an automated instrument (Dako) with
antibodies directed against GATA3, SALL4, and glypican
3. Fluorescence in situ hybridization (FISH) was performed on formalin-fixed, paraffin-embedded sections,
using methods previously described.3

Results
A 12-year-old boy presented with limb swelling, increased
appetite, weight gain, precocious puberty, headache, and
vomiting. Subsequent evaluation with computed
1

Henry Ford Health System, Henry Ford Hospital, Detroit, MI, USA
Barrow Neurological Institute, Phoenix, AZ, USA
3
Indiana University, Indianapolis, IN, USA
4
University of Wisconsin, Madison, WI, USA
5
Wayne State University, Detroit, MI, USA
2

* These authors contributed equally to the study.
Corresponding Author:
Sean R. Williamson, Department of Pathology and Laboratory Medicine,
Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI 48202, USA.
Email: williamson.sean@outlook.com

2

International Journal of Surgical Pathology XX(X)

Figure 1. Magnetic resonance imaging pre-treatment shows a heterogeneous, intermediate signal mass, which is isointense to gray
matter in the axial T2 image (left). The axial post-gadolinium image (right) shows avid enhancement.

tomography and magnetic resonance imaging (MRI)
revealed a 5-cm right frontal lobe mass (Figure 1). Serum
a-fetoprotein (AFP; 2939 IU/mL) and b-human chorionic
gonadotrophin (hCG; 15 522 IU/mL) were elevated. After
good response to 6 cycles of neoadjuvant carboplatin, etoposide, and ifosfamide, the tumor was resected. Two
cycles of adjuvant chemotherapy, and 54 Gy of adjuvant
proton beam radiation to the craniospinal and right frontal
areas were administered. The patient has been disease-free
during follow-up studies with hCG and AFP at 13 years
after primary treatment.
At gross examination, the resected tissue showed a
tan gray, lobulated, firm appearance. On cut surface, the
lesion was slightly whorled and consisted of lobulated
tan tissue with focal red-black, pinpoint, hemorrhagic
foci in cysts. Histologically, the lesion was composed
of predominantly smooth muscle, punctuated by minute
foci of glandular and cystic trophoblastic elements
(Figure 2A-C). The lining of the cystic spaces was composed of cells with a trophoblastic appearance, including
multinucleated cells with smudged-appearing nuclei, and
central eosinophilic fibrinoid material. The biphasic pattern of choriocarcinoma was not present, nor was there
necrosis or hemorrhage. No definite yolk sac tumor was
appreciable. Immunohistochemical staining revealed
negative SALL4 and glypican 3, arguing against residual
yolk sac tumor. GATA3 was negative; however, the
CTT foci were not well visualized in the additional sections for immunohistochemistry. FISH revealed gain of
material from chromosome 12p (but not isochromosome
12p; Figure 2D).

Discussion
Cystic trophoblastic tumor is a likely under-recognized
entity in germ cell tumor classification with disputed
pathogenesis. Its true incidence is not entirely known,
due to the relative rarity of testicular cancer compared
with other cancers, and potentially underrecognition. One
hypothesis is that this represents a regressing choriocarcinoma, with stepwise degeneration of solid to cystic
component as the more aggressive cells are eliminated
by chemotherapy or spontaneous regression. This leads to
the persistence of a slow growing, less aggressive component of intermediate-type trophoblastic cells that
develop into CTT.3
Morphologically, CTT may consist of solid foci or
small clusters of modestly pleomorphic trophoblastic
cells, and variably sized, degenerative appearing cysts,
typically measuring <3 mm with circumscribed borders.
Cysts are lined by trophoblast cells with abundant, eosinophilic cytoplasm that vary from a single cell layer to
several in thickness, forming intracystic papillary tufts or
cribriform arrangements. Most of the lining cells are
mononucleated and many have a “smudged” chromatin
pattern, although occasional multinucleated cells occur,
sometimes with cytoplasmic lacunae. Many of the lining
cells have a squamoid appearance, although no extracellular keratin production is apparent. Mitotic activity is
inconspicuous, with only rare mitotic figures identified.1,2
In general, cystic trophoblastic elements would have a
differential diagnosis that includes somatic malignancy,
especially squamous cell carcinoma, trophoblastic

Gadde et al

3

Figure 2. (A) Histologic examination of the post-treatment resection showed predominantly smooth muscle tissue punctuated by
minute teratomatous glands (arrows). (B) Rare cystic trophoblastic elements were noted, forming cystic structures lined by cells of
varying sizes. (C) Higher magnification of the trophoblastic lining shows multilayering of cells with variable nuclear size and larger nuclei
showing a smudged appearance of the chromatin. (D) Fluorescence in situ hybridization evaluation shows multiple copies of the 12p
probe (green, arrow), compared with the centromere (red).

differentiation including epithelioid trophoblastic tumor,
placental site trophoblastic tumor, or unclassified trophoblastic tumor. These can be excluded by careful histologic
examination and immunohistochemistry. Squamous cell

carcinoma would be negative for hCG and inhibin, and
importantly, one should not diagnose a secondary somatic
malignancy of germ cell tumor origin unless there is overgrowth of a single element more than an entire 4 field (5

4
mm diameter), which is rarely the case with CTT. Epithelioid trophoblastic tumor usually forms cohesive nests of
squamoid cells with abundant cytoplasm and mostly single, pleomorphic, and hyperchromatic nuclei with variable prominent nuclei. Choriocarcinoma can be excluded
by absence of the biphasic pattern of cytotrophoblastic
and syncytiotrophoblastic cells with associated hemorrhage or necrosis.
Cystic trophoblastic tumor is known for its low malignant potential, noninfiltrative pattern, and low mitotic
index.3 Current thinking is that the prognosis comparable
to residual teratoma and that patients usually do not
require additional chemotherapy.4 Germ cell tumors other
than teratoma in patients who had chemotherapy are associated with recurrence and typically considered to require
additional chemotherapy.5,6 FISH studies in the current
case revealed gain of chromosome 12p, although not isochromosome 12p, which is a molecular alteration that has
been described in both testicular and primary nervous system germ cell tumors.7
In this report, we describe, to our knowledge, the first
example of CTT in a central nervous system germ cell
tumor, occurring in a 12-year-old boy. The patient had
an excellent response to therapy and is disease-free at 13
years of follow-up, implying good prognosis, similar to
CTT found in post-chemotherapy residual retroperitoneal
masses in testicular germ cell tumor patients. Awareness
of this entity in the nervous system expands the current
knowledge of primary germ cell tumors at this site and
may potentially guide adjuvant therapy.
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